Fundraising FoxSignet Healthcare Partners — 2025 Investments
2 investments dated 2025 · listed companies and verified rows first · show all
Ascendia Pharmaceutical Solutions is a contract development and manufacturing organization (CDMO) that provides formulation, nanotechnology, and manufacturing services for pharmaceutical and biological companies from pre-formulation through commercialization.
Advanced ManufacturingBiotechHealthtechMedical DevicesNorth Brunswick, US
Jingjun Huang(Executive Officer, Director)
BoardRobert Bloder(Director)Michael Bogda(Director)inShoufeng Li(Director)Theron Odlaug(Director)
Board seatJames Gale· per SEC Form D
PainTEQ develops medical devices and implants for sacroiliac joint dysfunction, offering solutions ranging from biologicalbone allografts to titanium implants as alternatives to injections or fusion surgery.
Deep TechHealthtechMedical DevicesTampa, US
Shanth(Chief Executive Officer)
Co-investorsWindham Capital Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.